Home/ Supplements/ Vitamin K/ Full Spectrum Vitamin K

Full Spectrum Vitamin K

product on market Softgel Capsule Allergy Research Group Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This formula contains vitamins A, C, D3, and K, which are supported by strong evidence for maintaining immune function and bone health. The inclusion of DeltaGOLD provides additional antioxidant support, though evidence for this specific component is more limited. Overall, these ingredients are well-researched for their roles in systemic physiological maintenance.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Full Spectrum Vitamin K
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
90
Servings
Other Combinations
Product Type
40%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
60 mcg RAE (7% DV)
Vitamin C
25 mg (28% DV)
10 mcg (50% DV)
Within RDA (0.7× RDA) 608 studies (A:16, B:251)
4.05 mg (3375% DV)
33.8× RDA — above typical dose 275 studies (A:9, B:175)
DeltaGOLD
5 mg

Other Ingredients

Sunflower Oil Gelatin Glycerin Water Yellow Beeswax Soy Lecithin
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Suggested Use As a dietary supplement, 1 softgel one or two times daily with meals, or as directed by a healthcare practitioner. Taking with a fat-containing meal may further enhance absorption.

Warnings & Precautions

Contraindicated with use of anticoagulant drugs.

Contains: Soy, fish.

Formulation Notes

Full Spectrum Vitamin K Full Spectrum Vitamin K is a comprehensive vitamin K formula containing vitamins K1 and K2, as well as vitamins A and D, and vitamin E as gamma and delta tocotrienols.

Full Spectrum Vitamin K Three Forms of K with A, D, and E

Additional Information

Keep in a cool, dry place, tightly capped.

Metadata

Product Details

UPC / SKU7 13947 75390 7
DSLD Entry Date2024-09-25
Product TypeOther Combinations
FormSoftgel Capsule
BrandAllergy Research Group
DSLD ID317592
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

Vitamin K-2
GNC Preventive Nutrition · Softgel Capsule
100
Vitamin K-2
NewtonEverett · Softgel Capsule
100
Low-Dose Vitamin K2 45 mcg
Life Extension · Softgel Capsule
100
Natural Vitamin K-2 Bioactive Form
Vitamin World · Softgel Capsule
100
Vitamin K2 50 mcg
Vitacost · Softgel Capsule
100
View all Vitamin K products →
Vitamin K research Best Vitamin K All Vitamin K products More from Allergy Research Group View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.